Federal Register / Vol. 65, No. 192 / Tuesday, October 3, 2000 / Notices 59003

availability, costs and scope of private

health insurance benefits among

Americans;

• Examining the effects of changes in

how chronic care and disability are

managed and financed;

• Evaluating the growing impact of

managed care and of enrollment in

different types of managed care plans;

and

• Examining access to and costs of

health care for common diseases and

conditions, health care quality,

prescription drug use, and other health

issues.

Statisticians and researchers will use

these data to make important

generalizations on the civilian noninstitutionalized population of the

United States, as well as to conduct

research in which the family is the unit

of analysis.

Method of Collection

The data will be collected using a

combination of modes. For example, the

AHRQ intends to introduce study

participants to the survey through

advance mailings. The first contact will

provide the household with information

regarding the importance and uses of

the information obtained. The AHRQ

will then conduct five (in-person)

interviews with each household to

obtain health care use and expense data.

Data will be collected using a computerassisted personal interviewing method

(CAPI). In certain cases, AHRQ will

conduct interviews over the telephone,

if necessary. Burden estimates follow:

Estimated Annual Respondent Burden

Per Year

Each MEPS participant is asked to

complete 5 interviews over two and one

half years. Each interview averages 1.8

hours in length. Total burden is

estimated in the following chart.

Survey period Number of

completes

Burden per

complete

(hours)

Total burden

(hours)

Feb–July 2001 ............................................................................................................................. 19,380 1.8 34,884

August–Dec 2001 ........................................................................................................................ 13,280 1.8 23,904

Feb–July 2002 ............................................................................................................................. 21,248 1.8 34,246

Aug–Dec 2002 ............................................................................................................................. 16,239 1.8 29,230

Feb–July 2003 ............................................................................................................................. 24,187 1.8 43,537

148,291

Dated: September 27, 2000.

John M. Eisenberg,

Director.

[FR Doc. 00–25339 Filed 10–2–00; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[60Day–00–52]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Centers for Disease Control and

Prevention (CDC) is providing an

opportunity for public comment on

proposed data collection projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call the CDC Assistant

Reports Clearance Officer at 404–639–

7090.

Comments are invited on: (i) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the CDC, including

whether the information shall have a

practical utility; (ii) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (iii)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (iv) ways to minimize the

burden of the collection of information

on respondents, including the use of

automated collection techniques or

other forms of information technology.

Send comments to Anne O’Connor, CDC

Assistant Reports Clearance Officer,

1600 Clifton Road, MS–D24, Atlanta,

Georgia 30333. Written comments

should be received within 60 days of

this notice.

Proposed Project

Survey to Determine the National

Capacity to Provide Colorectal Cancer

Screening and Follow-up

Examinations—New—The National

Center for Chronic Disease Prevention

and Health Promotion, Division of

Cancer Prevention and Control,

proposes to conduct a study to provide

a national assessment of the current

capacity to conduct colorectal cancer

(CRC) screening and follow-up

examinations for average risk persons

aged 50 and older. Colorectal cancer is

the second leading cause of cancerrelated deaths in the United States.

While there is strong scientific evidence

that screening for CRC reduces

incidence and mortality from this

disease, rates of use of screening tests

are currently low. Efforts to promote

widespread screening for CRC are

intensifying among local, state, and

federal health agencies and professional

organizations nationwide. However,

limited information is available

regarding the number of health care

personnel currently trained and

available to perform screening and

follow-up examinations.

The proposed study will be

conducted through the implementation

of a survey which will be mailed to a

random sample of 1,800 providers

known to possess flexible

sigmoidoscopes and colonoscopes,

based upon lists provided by major

endoscopic equipment manufacturers.

The sampling frame will be designed to

include providers from all regions of the

country and all physician specialists

who may be screening for CRC. The

survey will provide information on the

types of health care providers who are

performing CRC screening and followup examinations, the equipment

currently being used for screening and

follow-up examinations, and current

reimbursement rates for these tests. The

results of the analysis will be used to (1)

identify deficits in the medical

infrastructure, (2) guide the

development of training initiatives and

educational programs for health care

providers, and (3) provide critical

baseline information for local, state and

federal policy makers for the planning

of national initiatives to increase

colorectal cancer screening. There is no

cost to respondents.

59004 Federal Register / Vol. 65, No. 192 / Tuesday, October 3, 2000 / Notices

Respondents Number of

respondents

Number of

responses/

respondent

Average

burden of

response

(in hrs.)

Total burden

(in hrs.)

Health Care Providers ..................................................................................... 1800 1 D20/60 600

Office Managers .............................................................................................. 1800 1 20/60 600

Totals ........................................................................................................ ........................ ........................ ........................ 1200

Dated: September 27, 2000.

Nancy Cheal,

Acting Associate Director for Policy, Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–25321 Filed 10–2–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Availability of Government-Owned

Trademark for Licensing

AGENCY: National Institute of

Occupational Safety and Health

(NIOSH), Centers for Disease Control

and Prevention (CDC), Department of

Health and Human Services (DHHS).

TITLE: Availability of a Governmentowned Trademark for Licensing: The

Registry of Toxic Effects of Chemical

Substances (RTECS).

ACTION: Notice and request for

proposals. NIOSH is requesting

proposals for the purpose of establishing

a licensing agreement for the

continuation of a trademarked product:

RTECS. (The NIOSH Trademark

named in this notice is owned by the

United States Government and is

available or licensing in the United

States (U.S.), in accordance with 35

U.S.C. 207 to achieve expeditious

commercialization of results of federally

funded research and development.)

SUMMARY: From the 1971 initial release

of the mandated Toxic Substances List,

the National Institute for Occupational

Safety and Health (NIOSH) has been

systematically building and updating

the Registry of Toxic Effects of Chemical

Substances (RTECS). RTECS was

originally published in book format,

later a microfiche version was

developed. Currently, RTECS is

available in a digital format for

electronic delivery. RTECS is

recognized as the world’s most

extensive collection of numerical

toxicological data. Because RTECS

identifies specific toxicological

endpoints, it has a unique status among

databases that provide toxicology

information. RTECS is used not only

by the occupational safety and health

community; it serves as a standard

reference for life-science scientists and

regulatory groups from all parts of the

world. Both its content and design have

contributed to its wild spread use, thus

making RTECS a commercially viable

product. NIOSH is now soliciting

proposals from organizations interested

in assuming the responsibility for the

continued operation and funding of

RTECS. This include the ongoing

review of toxicological documents,

extraction and updating of appropriate

information as well as the marketing

and distribution of the RTECS database

through a trademark licensing

agreement.

DATES: Written licensing proposals can

be sent to Thomas E. O’Toole, M.P.H.,

Deputy Director, Technology Transfer

Office, Centers for Disease Control and

Prevention (CDC), Mailstop E–67, 1600

Clifton Road, Atlanta, Georgia 30333 on

or before December 4, 2000.

FOR FURTHER INFORMATION CONTACT:

Doris Sweet, Education and Information

Division, Information Resources Branch,

NIOSH, CDC 4676 Columbia Parkway,

Mailstop C–18, Cincinnati, Ohio 45226,

telephone 513–533–8359, e-mail

address: dvs1@cdc.gov.

SUPPLEMENTARY INFORMATION:

RTECS Trademark License Proposal

1. Exclusive use of the RTECS name

for the production and marketing of the

database. The Licensee will have

unlimited right to the use of the

RTECS name for product identification

and promotion as related to selling and

marketing the production of the

Database.

2. Control of the current RTECS

Master File. The Licensee will provided

with a copy of the last NIOSH-produced

RTECS Master File and the CODEN

File. The Licensee may reformat the

data, provided the six toxicity fields

remain intact. New fields may be added

for the enhancement of the Database

(e.g. physical and chemical properties,

structural formulas, author names).

Selected fields may be deleted if the

worth or power of the Database is not

diminished (e.g., Wiswesser Line

Notation).

3. Authority and responsibility for

vendor agreements. Upon execution of

this agreement, the National Technical

Information Service (NTIS), currently

serving as broker for NIOSH, will notify

all current vendors that existing vendor

agreements will terminate after ninety

(90) days. Thereafter, vendor agreements

become the responsibility of the

Licensee, who may decide to extend

existing agreements until the expiration

date, or to negotiate new agreements

with all vendors. The Licensee will not

be bound by any previous agreements

with NTIS, unless they chose to

negotiate with that organization.

4. Access to comprehensive

documentation. NIOSH will provide

access to the collection of all source

references cited in RTECS. These are

an essential tool in accessing the

original documentation cited in the

Database. In order to assure full

historical information, NIOSH will also

provide access to a complete collection

of printed editions of RTECS, from

1971 to 1985–86, and annual microfiche

editions beyond 1987.

5. NIOSH consultation services.

NIOSH will provide support to the

Licensee through participation on any

established Board/Committee

empowered to modify the Database.

NIOSH Requirements To Be Addressed

in the Proposal

1. Maintenance of RTECS as a viable

toxicological database. The Licensee

must maintain the quality of the

Database, making only such changes

that will enhance its value and power,

and those mandated by changing

technologies. The adoption of alternate

test methods will require an altered

approach. The proposal should address

plans for coverage of current

toxicological literature on an

international scale.

2. Preservation of international

literature coverage. The proposal shall

address the manner in which the

continued coverage of international

literature will be accomplished. Because

much of the current data now originates

from outside the United States,

especially in the Orient and Eastern

Europe, access to linguistic skills is

vital.